Therapeutic implications for sphingolipid metabolism in metabolic dysfunction-associated steatohepatitis
The prevalence of metabolic dysfunction-associated steatotic liver disease (MASLD), a leading cause of chronic liver disease, has increased worldwide along with the epidemics of obesity and related dysmetabolic conditions characterized by impaired glucose metabolism and insulin signaling, such as ty...
Na minha lista:
| Principais autores: | , , , , , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Frontiers Media S.A.
2024-06-01
|
| coleção: | Frontiers in Endocrinology |
| Assuntos: | |
| Acesso em linha: | https://www.frontiersin.org/articles/10.3389/fendo.2024.1400961/full |
| Tags: |
Sem tags, seja o primeiro a adicionar uma tag!
|
